Cargando…

Retinol-binding protein 4 in combination with lipids to predict the regression phenomenon of autism spectrum disorders

BACKGROUND: About 20–40 % of autistic people experience a phenomenon of regression. Retinol binding protein 4 (RBP4) plays an important role as an inflammatory neurotrophic adipokine and is a promising mediator of the fat-brain axis. Abnormal fatty acid metabolism and lipid mediators have been repor...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jianling, Chen, Jing, Xu, Yun, Cheng, Peipei, Yu, Shunying, Fu, Yingmei, Du, Yasong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390196/
https://www.ncbi.nlm.nih.gov/pubmed/34446012
http://dx.doi.org/10.1186/s12944-021-01522-9
_version_ 1783743041745453056
author Chen, Jianling
Chen, Jing
Xu, Yun
Cheng, Peipei
Yu, Shunying
Fu, Yingmei
Du, Yasong
author_facet Chen, Jianling
Chen, Jing
Xu, Yun
Cheng, Peipei
Yu, Shunying
Fu, Yingmei
Du, Yasong
author_sort Chen, Jianling
collection PubMed
description BACKGROUND: About 20–40 % of autistic people experience a phenomenon of regression. Retinol binding protein 4 (RBP4) plays an important role as an inflammatory neurotrophic adipokine and is a promising mediator of the fat-brain axis. Abnormal fatty acid metabolism and lipid mediators have been reported to be related to the etiological mechanism in autism, and amelioration of impaired lipid metabolism can be recognized as a treatment strategy for autism. The purpose of this study is to explore the relationship between RBP4, lipids, and the autistic regression phenomenon, and to discuss their potentials as biomarkers for the autistic regression phenomenon. METHODS: A total of 60 autistic individuals (18 with regression phenomenon, 42 without regression phenomenon) (ASD group) and 36 healthy controls were enrolled in this case-control study. The levels of RBP4, total cholesterol (TC), high-density lipoprotein (HDLC), low–density lipoprotein (LDLC), and triglyceride (TG) were measured. Childhood Autism Rating Scale (CARS) is used to assess the severity of autism. Ethical measures were performed in compliance with the current Declaration of Helsinki and written informed consent was obtained from the parents before enrollment of the children and adolescents. RESULTS: Compared with control subjects, autistic individuals had lower levels of TC (P = 0.007), RBP4 (P = 0.001), and HDLC (P = 0.027). The levels of RBP4 in ASD group were positively correlated with TG (r = 0.355, P = 0.005), HDLC (r = 0.257, P = 0.047), TG/TC (r = 0.376, P = 0.003) and TG/LDLC (r = 0.363, P = 0.004), and were negatively correlated with CARS (r=-0.296, P = 0.003). Further logistic regression demonstrated that decreased RBP4 concentration was associated with the presentation of the autistic regression phenomenon even after the adjustment of the potential confounding factors. CONCLUSIONS: Serum RBP4 is associated with the autistic regression phenomenon and the severity of ASD. Further studies are needed to expound whether decreased RBP4 participates in the development of the autistic regression phenomenon.
format Online
Article
Text
id pubmed-8390196
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-83901962021-08-27 Retinol-binding protein 4 in combination with lipids to predict the regression phenomenon of autism spectrum disorders Chen, Jianling Chen, Jing Xu, Yun Cheng, Peipei Yu, Shunying Fu, Yingmei Du, Yasong Lipids Health Dis Research BACKGROUND: About 20–40 % of autistic people experience a phenomenon of regression. Retinol binding protein 4 (RBP4) plays an important role as an inflammatory neurotrophic adipokine and is a promising mediator of the fat-brain axis. Abnormal fatty acid metabolism and lipid mediators have been reported to be related to the etiological mechanism in autism, and amelioration of impaired lipid metabolism can be recognized as a treatment strategy for autism. The purpose of this study is to explore the relationship between RBP4, lipids, and the autistic regression phenomenon, and to discuss their potentials as biomarkers for the autistic regression phenomenon. METHODS: A total of 60 autistic individuals (18 with regression phenomenon, 42 without regression phenomenon) (ASD group) and 36 healthy controls were enrolled in this case-control study. The levels of RBP4, total cholesterol (TC), high-density lipoprotein (HDLC), low–density lipoprotein (LDLC), and triglyceride (TG) were measured. Childhood Autism Rating Scale (CARS) is used to assess the severity of autism. Ethical measures were performed in compliance with the current Declaration of Helsinki and written informed consent was obtained from the parents before enrollment of the children and adolescents. RESULTS: Compared with control subjects, autistic individuals had lower levels of TC (P = 0.007), RBP4 (P = 0.001), and HDLC (P = 0.027). The levels of RBP4 in ASD group were positively correlated with TG (r = 0.355, P = 0.005), HDLC (r = 0.257, P = 0.047), TG/TC (r = 0.376, P = 0.003) and TG/LDLC (r = 0.363, P = 0.004), and were negatively correlated with CARS (r=-0.296, P = 0.003). Further logistic regression demonstrated that decreased RBP4 concentration was associated with the presentation of the autistic regression phenomenon even after the adjustment of the potential confounding factors. CONCLUSIONS: Serum RBP4 is associated with the autistic regression phenomenon and the severity of ASD. Further studies are needed to expound whether decreased RBP4 participates in the development of the autistic regression phenomenon. BioMed Central 2021-08-26 /pmc/articles/PMC8390196/ /pubmed/34446012 http://dx.doi.org/10.1186/s12944-021-01522-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Chen, Jianling
Chen, Jing
Xu, Yun
Cheng, Peipei
Yu, Shunying
Fu, Yingmei
Du, Yasong
Retinol-binding protein 4 in combination with lipids to predict the regression phenomenon of autism spectrum disorders
title Retinol-binding protein 4 in combination with lipids to predict the regression phenomenon of autism spectrum disorders
title_full Retinol-binding protein 4 in combination with lipids to predict the regression phenomenon of autism spectrum disorders
title_fullStr Retinol-binding protein 4 in combination with lipids to predict the regression phenomenon of autism spectrum disorders
title_full_unstemmed Retinol-binding protein 4 in combination with lipids to predict the regression phenomenon of autism spectrum disorders
title_short Retinol-binding protein 4 in combination with lipids to predict the regression phenomenon of autism spectrum disorders
title_sort retinol-binding protein 4 in combination with lipids to predict the regression phenomenon of autism spectrum disorders
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390196/
https://www.ncbi.nlm.nih.gov/pubmed/34446012
http://dx.doi.org/10.1186/s12944-021-01522-9
work_keys_str_mv AT chenjianling retinolbindingprotein4incombinationwithlipidstopredicttheregressionphenomenonofautismspectrumdisorders
AT chenjing retinolbindingprotein4incombinationwithlipidstopredicttheregressionphenomenonofautismspectrumdisorders
AT xuyun retinolbindingprotein4incombinationwithlipidstopredicttheregressionphenomenonofautismspectrumdisorders
AT chengpeipei retinolbindingprotein4incombinationwithlipidstopredicttheregressionphenomenonofautismspectrumdisorders
AT yushunying retinolbindingprotein4incombinationwithlipidstopredicttheregressionphenomenonofautismspectrumdisorders
AT fuyingmei retinolbindingprotein4incombinationwithlipidstopredicttheregressionphenomenonofautismspectrumdisorders
AT duyasong retinolbindingprotein4incombinationwithlipidstopredicttheregressionphenomenonofautismspectrumdisorders